2026 Trends in Drug Benefit Design Report
PSG announces the results of its extensive research on the latest trends in drug benefit design. Plan sponsors face complex decisions and challenges…
Read Post
Insights
Categories
Topics
Categories
Topics
2025 Trends in Drug Benefit Design Report Webinar
PSG announces the results of its extensive research on the latest trends in drug benefit design. Plan sponsors face complex decisions and challenges…
Read Post
Payers Seeking Innovative Solutions to Control Specialty Drug Costs as Pharmacy Benefit Landscape Evolves Rapidly
New Survey Reveals 84% of Payers Prioritize Total Cost Management as Cell and Gene Therapies Present Unprecedented Challenges DALLAS, TX – Employers and health…
Read Post
2025 Trends in Specialty Drug Benefits Report
PSG announces the results of its extensive research on the latest trends in specialty drug benefits. This exclusive research offers comprehensive insights to…
Read Post
2026 Medicare Final Rule: Key Implications for Health Plan Pharmacy Leaders
The Centers for Medicare & Medicaid Services (CMS) has released its final rule outlining significant pharmacy changes for Medicare and…
Read Post
OptumRx Prior Authorization Changes: What Does It Actually Mean For Patients, Providers, and Payers
Understand Considerations for OptumRx’s PA Announcement OptumRx (Optum) recently announced significant changes to its prior authorization program, eliminating the reauthorization process for 80…
Read Post
Learnings from the Latest Pharmacy Benefit Fiduciary Lawsuit Developments
Proactive Pharmacy Benefit Oversight in an Evolving Legal Landscape In the first quarter of 2025, plan fiduciaries witnessed significant news about and movement on…
Read Post
2025 Trends in Specialty Drug Benefits Report Webinar
PSG announces the results of its extensive research on the latest trends in specialty drug benefits. This exclusive research offers comprehensive insights to…
Read Post
Empowering Health Plans with Innovative Solutions to Accelerate PBM Transparency
As a health plan pharmacy leader, you steward millions if not billions in annual pharmacy spend. Yet, as you know, translating complex Pharmacy Benefit…
Read Post
Integrated Insights, Clinical Connections: Migraines
Leverage Integrated Data to Inform Better Benefit Decisions Migraines are more than just headaches, they’re a significant health challenge affecting millions of Americans,…
Read Post
CGT Space Faces Some Challenges, but There ‘Still Is a Place’ for Therapies
Reprinted with AIS Health permission from the March 2025 issue of Radar on Specialty Pharmacy. The cell and gene therapy (CGT) space…
Read Post
Navigating Medicare’s Complexities: Profitability Strategies for Pharmacy Leaders
Amid evolving Medicare regulations and market dynamics, payer leaders face unprecedented challenges in maintaining profitability while delivering quality care. Join our team of Medicare…
Read Post